'Protecting Life in Global Health Assistance'? Towards a framework for assessing the health systems impact of the expanded Global Gag Rule.
health policy
health systems
hiv
maternal health
public health
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
2019
2019
Historique:
received:
20
06
2019
revised:
11
07
2019
accepted:
13
07
2019
entrez:
1
10
2019
pubmed:
1
10
2019
medline:
1
10
2019
Statut:
epublish
Résumé
During his first week in office, US President Donald J Trump issued a presidential memorandum to reinstate and broaden the reach of the Mexico City policy. The Mexico City policy (which was in place from 1985-1993, 1999-2000 and 2001-2009) barred foreign non-governmental organisations (NGOs) that received US government family planning (FP) assistance from using US funds or their own funds for performing, providing counselling, referring or advocating for safe abortions as a method of FP. The renamed policy, Protecting Life in Global Health Assistance (PLGHA), expands the Mexico City policy by applying it to most US global health assistance. Thus, foreign NGOs receiving US global health assistance of nearly any type must agree to the policy, regardless of whether they work in reproductive health. This article summarises academic and grey literature on the impact of previous iterations of the Mexico City policy, and initial research on impacts of the expanded policy. It builds on this analysis to propose a hypothesis regarding the potential impact of PLGHA on health systems. Because PLGHA applies to much more funding than it did in its previous iterations, and because health services have generally become more integrated in the past decade, we hypothesise that the health systems impacts of PLGHA could be significant. We present this hypothesis as a tool that may be useful to others' and to our own research on the impact of PLGHA and similar exogenous overseas development assistance policy changes.
Identifiants
pubmed: 31565418
doi: 10.1136/bmjgh-2019-001786
pii: bmjgh-2019-001786
pmc: PMC6747899
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e001786Investigateurs
Bergen Cooper
(B)
Dennis Juko
(D)
Elizabeth Sully
(E)
Emily Maistrellis
(E)
Hana Thomas
(H)
Heidi Quinn
(H)
Isaiah Oyango
(I)
Jamie Vernaelde
(J)
Jennifer Britton
(J)
Jennifer Redner
(J)
Jennifer Sherwood
(J)
Katy Footman
(K)
Kathryn Roberts
(K)
Latanya Mapp Frett
(LM)
Luisa Orza
(L)
Lynn Freedman
(L)
Maggie Giorgio
(M)
Margo Mullinax
(M)
Kate Hesel
(K)
Marta Schaaf
(M)
Pari Chowdhary
(P)
Patty Skuster
(P)
Roger Rochat
(R)
Sara Casey
(S)
Sara van Belle
(S)
Sruthi Chandrasekaran
(S)
Saumya Ramarao
(S)
Simone Santos
(S)
Terry McGovern
(T)
Vanessa Rios
(V)
Yana Rogers
(Y)
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Dev Areas. 1998 Winter;32(2):221-36
pubmed: 12294125
Bull World Health Organ. 2011 Dec 1;89(12):873-880C
pubmed: 22271944
Stud Fam Plann. 2005 Sep;36(3):235-45
pubmed: 16209180
Curr HIV/AIDS Rep. 2016 Jun;13(3):170-6
pubmed: 27221628
Health Policy Plan. 1996 Dec;11(4):339-53
pubmed: 10164192
Health Qual Life Outcomes. 2017 Sep 29;15(1):188
pubmed: 28962570
AIDS Care. 2012;24(11):1442-7
pubmed: 22296261
Global Health. 2013 Jul 26;9(1):30
pubmed: 23889824
N Engl J Med. 2011 Jun 9;364(23):2181-3
pubmed: 21651390
Lancet Glob Health. 2019 Aug;7(8):e1046-e1053
pubmed: 31257094